Custom Search
Divalproex News
Epilepsy Drug Eases Symptoms Of Inherited Disorder That Weakens Muscles
An epilepsy drug that has been on the market for decades can ease the symptoms of adult sufferers with a genetic disorder that seriously weakens muscles.
Wockhardt gets US approval for anti-epileptic drug
Mumbai, India's leading pharmaceutical and biotechnology firm Wockhardt Ltd Wednesday said it has received an approval from the Food and Drug Administration (FDA) of the US for its anti-epileptic drug Divalproex Sodium.
Teva Announces Tentative Approval of Divalproex Sodium Delayed-Release Tablets
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted tentative approval for the Company's ANDA for Divalproex Sodium Delayed-Release Tablets USP, 125 mg, 250 mg...
Abbott's Depakote ER (Divalproex Sodium Extended-Release Tablets) Approved for Acute Manic or Mixed Episodes Associated With Bipolar Disorder
Extended-Release Formulation Offers Patients Conveniences of Once-Daily Therapy.
Displaying results 6 to 9 out of 9